Detection and prediction of carboplatin-related hypersensitivity reaction in patients with gynecologic cancer using basophil CD203c.

• DOI: 10.1200/jco.2011.29.15_suppl.e19504
• Publication Date: 2017-02-23T18:58:03Z
• Authors: T. Iwamoto; A. Yuta; T. Tabata; H. Sugimoto; H. Hirai; S. Kojima; E. C. Gabazza; N. Sagawa; M. Okuda

e19504 Background: Hypersensitivity reaction (HR) to carboplatin (CBDCA) restrains adequate therapy in cancer patients. Reliable in vitro test to detect and predict HR to carboplatin is not current...